ATRI - Atrion Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
657.90
+16.00 (+2.49%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close641.90
Open641.60
Bid64.30 x 0
Ask657.80 x 0
Day's Range641.60 - 663.05
52 Week Range516.85 - 694.25
Volume15,965
Avg. Volume6,217
Market Cap1.219B
Beta0.17
PE Ratio (TTM)36.03
EPS (TTM)18.26
Earnings DateNov 6, 2018 - Nov 12, 2018
Forward Dividend & Yield5.40 (0.86%)
Ex-Dividend Date2018-09-13
1y Target Est300.00
Trade prices are not sourced from all markets
  • Can Atrion Corporation’s (NASDAQ:ATRI) ROE Continue To Surpass The Industry Average?
    Simply Wall St.19 days ago

    Can Atrion Corporation’s (NASDAQ:ATRI) ROE Continue To Surpass The Industry Average?

    This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about Return on Equity using a real-life example. Atrion CorporationRead More...

  • GlobeNewswirelast month

    Atrion Corporation Increases Quarterly Cash Dividend by 13%

    ALLEN, Texas, Aug. 14, 2018-- Atrion Corporation today announced an increase in its quarterly cash dividend from $1.20 per share to $1.35 per share. Specifically, the Board of Directors declared a quarterly ...

  • Associated Press2 months ago

    Atrion: 2Q Earnings Snapshot

    On a per-share basis, the Allen, Texas-based company said it had net income of $4.74. Earnings, adjusted for pretax gains, were $4.70 per share. The medical device maker posted revenue of $38.8 million ...

  • GlobeNewswire2 months ago

    Atrion Reports Second Quarter Results

    ALLEN, Texas, Aug. 07, 2018-- Atrion Corporation today announced that for the second quarter ended June 30, 2018 revenues totaled $38.8 million compared with $36.2 million for the same period in 2017. ...

  • ACCESSWIRE4 months ago

    Blog Exposure - FDA Approved Expanded Indications for TransEnterix's Senhance Surgical System

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on TransEnterix, Inc. (NYSE: TRXC), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=TRXC as the Company's latest news hit the wire. On May 29, 2018, the Company announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for expanded indications of the Company's Senhance Surgical System for laparoscopic inguinal hernia and laparoscopic cholecystectomy (gallbladder removal) surgery.

  • Associated Press4 months ago

    Atrion: 1Q Earnings Snapshot

    The Allen, Texas-based company said it had net income of $4.57 per share. Earnings, adjusted for pretax gains, were $4.56 per share. The medical device maker posted revenue of $39.4 million in the period. ...

  • Where Atrion Corporation (NASDAQ:ATRI) Stands In Terms Of Earnings Growth Against Its Industry
    Simply Wall St.5 months ago

    Where Atrion Corporation (NASDAQ:ATRI) Stands In Terms Of Earnings Growth Against Its Industry

    Assessing Atrion Corporation’s (NASDAQ:ATRI) past track record of performance is a useful exercise for investors. It allows us to understand whether the company has met or exceed expectations, which isRead More...

  • ACCESSWIRE6 months ago

    Free Post Earnings Research Report: Mettler-Toledo’s Quarterly Earnings Increased 13.07%

    Stock Monitor: Atrion Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 12, 2018 / Active-Investors.com has just released a free earnings report on Mettler-Toledo International Inc. (NYSE: MTD ) ...

  • Atrion Corporation (NASDAQ:ATRI) Delivered A Better ROE Than The Industry, Here’s Why
    Simply Wall St.6 months ago

    Atrion Corporation (NASDAQ:ATRI) Delivered A Better ROE Than The Industry, Here’s Why

    Atrion Corporation (NASDAQ:ATRI) delivered an ROE of 19.85% over the past 12 months, which is an impressive feat relative to its industry average of 11.26% during the same period. WhileRead More...

  • Associated Press7 months ago

    Atrion posts 4Q profit

    On a per-share basis, the Allen, Texas-based company said it had net income of $4.66. The medical device maker posted revenue of $34 million in the period. For the year, the company reported profit of ...

  • Should You Be Tempted To Buy Atrion Corporation (NASDAQ:ATRI) Because Of Its PE Ratio?
    Simply Wall St.7 months ago

    Should You Be Tempted To Buy Atrion Corporation (NASDAQ:ATRI) Because Of Its PE Ratio?

    Atrion Corporation (NASDAQ:ATRI) is currently trading at a trailing P/E of 29.4x, which is lower than the industry average of 33.1x. While this makes ATRI appear like a great stockRead More...

  • Capital Cube10 months ago

    ETFs with exposure to Atrion Corp. : December 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Atrion Corp. Here are 5 ETFs with the largest exposure to ATRI-US. Comparing the performance and risk of Atrion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Atrion Corp. : ATRI-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 1, 2017
    Capital Cube10 months ago

    Atrion Corp. : ATRI-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Atrion Corp. with the following peers – Cooper Companies, Inc., STAAR Surgical Company, C. R. Bard, Inc., TearLab Corp., Teleflex Incorporated, Vuzix Corporation and SPY Inc. (COO-US, STAA-US, BCR-US, TEAR-US, TFX-US, VUZI-US and XSPY-US). Atrion Corp.’s dividend yield is 0.67 percent and its dividend payout ... Read more (Read more...)

  • Does Atrion Corporation’s (ATRI) 18.4% Earnings Growth Make It An Outperformer?
    Simply Wall St.10 months ago

    Does Atrion Corporation’s (ATRI) 18.4% Earnings Growth Make It An Outperformer?

    After reading Atrion Corporation’s (NASDAQ:ATRI) most recent earnings announcement (30 September 2017), I found it useful to look back at how the company has performed in the past and compareRead More...

  • Associated Press10 months ago

    Atrion posts 3Q profit

    On a per-share basis, the Allen, Texas-based company said it had profit of $4.29. The medical device maker posted revenue of $37.9 million in the period. Atrion shares have increased 28 percent since the ...